Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Teva
Cerilliant
Deloitte
Moodys
Queensland Health
McKinsey
Merck

Generated: May 23, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,451,458

« Back to Dashboard

Summary for Patent: 4,451,458
Title: Method for the treatment of post-operative thrombosis
Abstract:The invention provides novel pharmaceutical compositions useful in the treatment of thrombosis in mammals, comprising a mixture of dihydroergotamine or a related ergot alkaloid and heparin.
Inventor(s): Buhlmann; Hans (Nuremberg, DE), Welzel; Dieter (Nuremberg, DE)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/379,272
Patent Claims: 1. A method for the prophylactic treatment of post-operative thrombosis in mammals, comprising parenterally administering dihydroergotamine in conjunction with heparin, wherein the administration is effected with a unit dose comprising about 0.5 mg. of dihydroergotamine and about 2500-5000 I.U. of heparin and said doses are administered two to four times daily.

2. A pharmaceutical composition useful in the prophylactic treatment of post-operative thrombosis in mammals, comprising in unit dosage form about 0.5 mg. of dihydroergotamine and about 2500-5000 I.U. of heparin.

3. A pharmaceutical composition useful in the prophylactic treatment of post-operative thrombosis in mammals, comprising in unit dosage form about 0.5 mg. of dihydroergotamine and about 5000 I.U. of heparin.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Dow
Harvard Business School
Healthtrust
AstraZeneca
McKesson
Chubb
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.